Literature DB >> 7612230

Immune responses in MHC class II-deficient mice.

M J Grusby1, L H Glimcher.   

Abstract

Major histocompatibility complex (MHC) class II molecules are heterodimeric cell surface proteins that are critically important for the development and function of cells in the immune system. In particular, the maturation of CD4+ T cells is dependent on the expression of MHC class II molecules on thymic epithelium, while the activation of these cells requires the expression of class II molecules on specialized antigen-presenting cells in the periphery. The importance of class II molecules is especially evident in humans who are afflicted with MHC class II-deficient combined immunodeficiency, as these individuals die at an early age unless provided with a bone marrow transplant. Here we discuss the functional consequences of MHC class II deficiency in a mouse model generated by gene targeting in embryonic stem (ES) cells. These mice have proved to be valuable reagents for dissecting the mechanisms by which MHC class II molecules control the maturation and activation of lymphocytes as well as for elucidating the role of these cells in various immune responses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7612230     DOI: 10.1146/annurev.iy.13.040195.002221

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  29 in total

Review 1.  Regulation and function of class II major histocompatibility complex, CD40, and B7 expression in macrophages and microglia: Implications in neurological diseases.

Authors:  George M O'Keefe; Vince T Nguyen; Etty N Benveniste
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

2.  Autologous killing by a population of intermediate T-cell receptor cells and its NK1.1+ and NK1.1- subsets, using Fas ligand/Fas molecules.

Authors:  T Moroda; T Iiai; S Suzuki; A Tsukahara; T Tada; M Nose; K Hatakeyama; S Seki; K Takeda; H Watanabe; T Abo
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

3.  Ancient polymorphism and functional variation in the primate MHC-DQA1 5' cis-regulatory region.

Authors:  Dagan A Loisel; Matthew V Rockman; Gregory A Wray; Jeanne Altmann; Susan C Alberts
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-19       Impact factor: 11.205

4.  Functional CD8+ but not CD4+ T cell responses develop independent of thymic epithelial MHC.

Authors:  Marianne M Martinic; Maries F van den Broek; Thomas Rülicke; Christoph Huber; Bernhard Odermatt; Walter Reith; Edit Horvath; Raphael Zellweger; Katja Fink; Mike Recher; Bruno Eschli; Hans Hengartner; Rolf M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

5.  Gastric mucosal hyperplasia via upregulation of gastrin induced by persistent activation of gastric innate immunity in major histocompatibility complex class II deficient mice.

Authors:  T Fukui; A Nishio; K Okazaki; N Uza; S Ueno; M Kido; S Inoue; H Kitamura; K Kiriya; S Ohashi; M Asada; H Tamaki; M Matsuura; K Kawasaki; K Suzuki; K Uchida; H Fukui; H Nakase; N Watanabe; T Chiba
Journal:  Gut       Date:  2005-12-01       Impact factor: 23.059

Review 6.  Immune response to stem cells and strategies to induce tolerance.

Authors:  Puspa Batten; Nadia A Rosenthal; Magdi H Yacoub
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-08-29       Impact factor: 6.237

7.  Lineage targeted MHC-II transgenic mice demonstrate the role of dendritic cells in bacterial-driven colitis.

Authors:  Lillian Maggio-Price; Audrey Seamons; Helle Bielefeldt-Ohmann; Weiping Zeng; Thea Brabb; Carol Ware; Mingzu Lei; Robert M Hershberg
Journal:  Inflamm Bowel Dis       Date:  2013-01       Impact factor: 5.325

8.  MHC class II exacerbates demyelination in vivo independently of T cells.

Authors:  Meenaxi M Hiremath; Vivian S Chen; Kinuko Suzuki; Jenny P Y Ting; Glenn K Matsushima
Journal:  J Neuroimmunol       Date:  2008-10-15       Impact factor: 3.478

Review 9.  Responses against complex antigens in various models of CD4 T-cell deficiency: surprises from an anti-CD4 antibody transgenic mouse.

Authors:  Yifan Zhan; Lorena E Brown; Georgia Deliyannis; Shirley Seah; Odilia L Wijburg; Jason Price; Richard A Strugnell; Phillip J O'Connell; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

10.  Stem cells for heart cell therapies.

Authors:  Donghui Jing; Abhirath Parikh; John M Canty; Emmanuel S Tzanakakis
Journal:  Tissue Eng Part B Rev       Date:  2008-12       Impact factor: 6.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.